Related Experiment Video
Updated: Aug 5, 2026
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Methylazoxymethanol: effect on the immune response of rats to human serum albumin
Abstract:
Inbred male F344 rats treated with 20 mg methylazoxymethanol (MAM)/kg body weight showed minimal damage to DNA in bone marrow, spleen, and thymus and no suppression of the humoral immune response to human serum albumin (HSA). At high doses of MAM (40, 60, and 80 mg/kg), damage to DNA of bone marrow, spleen, and thymus was noted. The effect on the humoral immune responses was nonuniform. Some rats responded normally by eliciting precipitating antibodies, whereas others responded by synthesizing nonprecipitating antibodies at low levels. The production of nonprecipitating antibodies may indicate a restriction of the recognition of HSA antigenic determinants in rats given injections of MAM prior to immunization. The restriction may be a consequence of suppression or elimination of certain clones of lymphocytes responsible for recognition of certain antigenic determinants. This interference in some clones of lymphocytes would result in the synthesis of antibodies against one or two antigenic sites on the HSA and the concomitant inability of the produced antibodies to form complete lattice structure with antigen.
Insights
Methylazoxymethanol (MAM) exposure at high doses damages rat DNA and impairs immune responses. This damage can restrict lymphocyte recognition of antigens, leading to altered antibody production.
Area of Science:
- Toxicology
- Immunology
- Molecular Biology
Background:
- Methylazoxymethanol (MAM) is a chemical agent with potential genotoxic and immunotoxic effects.
- Understanding the dose-dependent effects of MAM on DNA integrity and humoral immunity is crucial for risk assessment.
Purpose of the Study:
- To investigate the impact of varying methylazoxymethanol (MAM) doses on DNA damage in key lymphoid organs.
- To evaluate the consequences of MAM exposure on the humoral immune response to human serum albumin (HSA).
Main Methods:
- Inbred male F344 rats were administered different doses of methylazoxymethanol (MAM).
- DNA damage was assessed in bone marrow, spleen, and thymus.
- Humoral immune response was measured by antibody production against human serum albumin (HSA).
Main Results:
- Low-dose MAM (20 mg/kg) caused minimal DNA damage and did not suppress the HSA humoral immune response.
- High-dose MAM (40-80 mg/kg) induced significant DNA damage in lymphoid tissues.
- High-dose MAM exposure resulted in a nonuniform immune response, with some rats producing nonprecipitating antibodies, suggesting restricted antigen recognition.
Conclusions:
- Methylazoxymethanol (MAM) exhibits dose-dependent genotoxicity and immunotoxicity.
- High MAM doses can impair lymphocyte function, leading to altered antibody repertoire and reduced immune efficacy.
- The observed immune dysregulation may stem from the elimination or suppression of specific lymphocyte clones responsible for recognizing certain antigenic determinants.
